9640 Medical Center Drive
PH: 1 (240) 864 2796
Visit CytImmune Sciences Website
Request Quote for Further Information
With a core focus in oncology, CytImmune will leverage its proprietary pegylated colloidal gold tumor-targeting nanotechnology to develop a new pipeline of multifunctional, next generation therapeutics with faster development timelines, more efficient regulatory approvals, new commercialization value, and greater patient benefit from a wide array of available anti-cancer agents.